SIRT1 and metabolic syndrome: Although the role of SIRT1 gene in carcinogenesis remains controversial [47], studies in various in vitro studies and in vivo models have found a significant association between the increases in NAD+ level and SIRT1 activity by fasting, exercise, and other chemopreventive regimens and the prevention of aging-related diseases, including cancer and metabolic syndrome [48–50].